Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, July 14, 2022
[ Thu, Jul 14th 2022
] - WOPRAI
[ Thu, Jul 14th 2022
] - WOPRAI
[ Thu, Jul 14th 2022
] - WOPRAI
[ Thu, Jul 14th 2022
] - WOPRAI
[ Thu, Jul 14th 2022
] - WOPRAI
[ Thu, Jul 14th 2022
] - WOPRAI
[ Thu, Jul 14th 2022
] - WOPRAI
[ Thu, Jul 14th 2022
] - WOPRAI
[ Thu, Jul 14th 2022
] - WOPRAI
[ Thu, Jul 14th 2022
] - WOPRAI
[ Thu, Jul 14th 2022
] - WOPRAI
[ Thu, Jul 14th 2022
] - WOPRAI
[ Thu, Jul 14th 2022
] - WOPRAI
[ Thu, Jul 14th 2022
] - WOPRAI
[ Thu, Jul 14th 2022
] - WOPRAI
[ Thu, Jul 14th 2022
] - WOPRAI
[ Thu, Jul 14th 2022
] - WOPRAI
[ Thu, Jul 14th 2022
] - WOPRAI
[ Thu, Jul 14th 2022
] - WOPRAI
[ Thu, Jul 14th 2022
] - WOPRAI
[ Thu, Jul 14th 2022
] - WOPRAI
[ Thu, Jul 14th 2022
] - WOPRAI
[ Thu, Jul 14th 2022
] - WOPRAI
[ Thu, Jul 14th 2022
] - WOPRAI
[ Thu, Jul 14th 2022
] - WOPRAI
[ Thu, Jul 14th 2022
] - WOPRAI
[ Thu, Jul 14th 2022
] - WOPRAI
[ Thu, Jul 14th 2022
] - WOPRAI
[ Thu, Jul 14th 2022
] - WOPRAI
Amit Hazan Maintained (TXG) at Hold with Decreased Target to $60 on, Jul 14th, 2022
Amit Hazan of Goldman Sachs, Maintained "10x Genomics, Inc." (TXG) at Hold with Decreased Target from $80 to $60 on, Jul 14th, 2022.
Amit has made no other calls on TXG in the last 4 months.
There are 2 other peers that have a rating on TXG. Out of the 2 peers that are also analyzing TXG, 0 agree with Amit's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Amit
- Tejas Savant of "Morgan Stanley" Maintained at Buy with Decreased Target to $100 on, Friday, May 6th, 2022
- Patrick Donnelly of "Citigroup" Maintained at Strong Buy with Decreased Target to $100 on, Thursday, May 5th, 2022
